To access this material please log in or register

Register Authorize

Coronary atherosclerosis in patients with chronic forms of ischemic heart disease in combination with chronic obstructive pulmonary disease (review)

Zafiraki V. K.1, Skaletsky K. V.1, Kosmacheva E. D.1, Shulzhenko L. V.1, Ramazanov D. M.2, Omarov A. A.3
1 – State Budgetary Educational Institution of Higher Professional Education, “Kuban State Medical University” of the RF Ministry of Health Care, Sedina 4, Krasnodar 350063
2 – Central Hospital of Oil Workers at the State Oil Company of the Azerbaijan Republic, Yusif Safarov 17, Baku AZ1025, Azerbaijan Republic
3 – Joint-Stock Company, “A. N. Syzganov National Science Center of Surgery”, Zheltoksan 62, Almaty, Kazakhstan Republic

Keywords: atherosclerosis, coronary heart disease, chronic obstructive pulmonary disease

DOI: 10.18087/rhj.2015.6.2124

Data accumulated by the present time evidence the existence of multiple pathogenetic links between IHD and chronic obstructive pulmonary disease (COPD). Such interaction results in more severe course of coronary atherosclerosis in patients with COPD. The review addressed and analyzed clinical studies evaluating the role of COPD in development and progression of coronary atherosclerosis using diagnostic methods such as ultrasonography, computed tomography, and coronary angiography.
  1. Global status report on noncommunicable diseases 2014. WHO Library Cataloguing-in-Publication Data. Geneva, 2014. – 398p.
  2. ВНОК. Кардиоваскулярная профилактика. Национальные рекомендации. Кардиоваскулярная терапия и профилактика. 2011;10 (6 Прил 2):1–64.
  3. Оганов Р. Г. Сердечно-сосудистые заболевания в начале XXI века: медицинские, социальные, демографические аспекты и пути профилактики. Медицина труда, восстановительная и профилактическая медицина. 2010;11:257–64.
  4. Петрухин И. С., Лунина Е. Ю. Актуальные проблемы профилактики сердечно-сосудистых заболеваний в России. 2012. Верхне­волжский медицинский журнал. 2012;10 (1):1–6.
  5. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007 Jun;29 (6):1224–38.
  6. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov;3 (11):e442.
  7. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006 Sep;28 (3):523–32.
  8. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI / WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001 Apr;163 (5):1256–76.
  9. Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012;7:457–94.
  10. Чучалин А. Г., Авдеев С. Н., Айсанов З. Р. и др. Российское респираторное общество. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни легких. Пульмонология. 2014;3:15–54.
  11. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring EJr, She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006 Jan;16 (1):63–70.
  12. Kawut SM. COPD: CardiOPulmonary Disease? Eur Respir J. 2013 Jun;41 (6):1241–3.
  13. Janssens JP, Herrmann F, MacGee W, Michel JP. Cause of death in older patients with anatomo-pathological evidence of chronic bronchitis or emphysema: a case-control study based on autopsy findings. J Am Geriatr Soc. 2001 May;49 (5):571–6.
  14. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J. 2003 Nov;22 (5):809–14.
  15. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005 Oct;128 (4):2640–6.
  16. Ghoorah K, De Soyza A, Kunadian V. Increased cardiovascular risk in patients with chronic obstructive pulmonary disease and the potential mechanisms linking the two conditions: a review. Cardiol Rev. 2013 Jul-Aug;21 (4):196–202.
  17. Soriano JB, Rigo F, Guerrero D, Yañez A, Forteza JF, Frontera G et al. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest. 2010 Feb;137 (2):333–40.
  18. Rutten FH, Hoes AW. Chronic obstructive pulmonary disease: a slowly progressive cardiovascular disease masked by its pulmonary effects? Eur J Heart Fail. 2012 Apr;14 (4):348–50.
  19. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challen­ges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007 Jan 16;49 (2):171–80.
  20. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 Mar 5;105 (9):1135–43.
  21. Gauss S, Klinghammer L, Steinhoff A, Raaz-Schrauder D, Marwan M, Achenbach S, Garlichs CD. Association of systemic inflammation with epicardial fat and coronary artery calcification. Inflamm Res. 2015 May;64 (5):313–9.
  22. Konecny T, Somers K, Orban M, Koshino Y, Lennon RJ, Scanlon PD, Rihal CS. Interactions between COPD and outcomes after percutaneous coronary intervention. Chest. 2010 Sep;138 (3):621–7.
  23. Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res. 2013 Oct;162 (4):237–51.
  24. Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R. Atherosclerosis and oxidative stress. Histol Histopathol. 2008 Mar;23 (3):381–90.
  25. Papaharalambus CA, Griendling KK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med. 2007 Feb;17 (2):48–54.
  26. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med. 1996 Oct;154 (4 Pt 1):1055–60.
  27. Macnee W, Maclay J, McAllister D. Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008 Dec 1;5 (8):824–33.
  28. Maclay JD, Macnee W. Cardiovascular disease in COPD: mechanisms. Chest. 2013 Mar;143 (3):798–807.
  29. Lattimore JD, Wilcox I, Nakhla S, Langenfeld M, Jessup W, Celermajer DS. Repetitive hypoxia increases lipid loading in human macrophages – a potentially atherogenic effect. Atherosclerosis. 2005 Apr;179 (2):255–9.
  30. Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A, Polotsky VY. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med. 2007 Jun 15;175 (12):1290–7.
  31. Curtis BM, O’Keefe JH. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc. 2002 Jan;77 (1):45–54.
  32. Heindl S, Lehnert M, Criee CP, Hasenfuss G, Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med. 2001 Aug 15;164 (4):597–601.
  33. Thomson AJ, Drummond GB, Waring WS, Webb DJ, Maxwell SR. Effects of short-term isocapnic hyperoxia and hypoxia on cardiovascular function. J Appl Physiol (1985). 2006 Sep;101 (3):809–16.
  34. Suissa S, Assimes T, Ernst P. Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarction. Thorax. 2003 Jan;58 (1):43–6.
  35. Suissa S, Hemmelgarn B, Blais L, Ernst P. Bronchodilators and acute cardiac death. Am J Respir Crit Care Med. 1996 Dec;154 (6 Pt 1):1598–602.
  36. Au DH, Curtis JR, Every NR, McDonell MB, Fihn SD. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest. 2002 Mar;121 (3):846–51.
  37. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007 Feb 22;356 (8):775–89.
  38. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW et al. Cardiovascular events in patients with COPD: TORCH study results. Thorax. 2010 Aug;65 (8):719–25.
  39. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med. 2009 Jul 4;360 (23):2445–54.
  40. Roversi S, Roversi P, Spadafora G, Rossi R, Fabbri LM. Coronary artery disease concomitant with chronic obstructive pulmonary disease. Eur J Clin Invest. 2014 Jan;44 (1):93–102.
  41. Fruchter O, Yigla M, Kramer MR. Lipid profile and statin use: the paradox of survival after acute exacerbation of chronic obstructive pulmonary disease. Am J Med Sci. 2015 Apr;349 (4):338–43.
  42. Neukamm A, Hоiseth AD, Einvik G, Lehmann S, Hagve TA, Sоyseth V, Omland T. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial. J Intern Med. 2015 Jul;278 (1):59–67.
  43. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte MJr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990 Mar 15;15 (4):827–32.
  44. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003 Sep;228 (3):826–33.
  45. Clouse ME. How useful is computed tomography for screening for coronary artery disease? Noninvasive screening for coronary artery disease with computed tomography is useful. Circulation. 2006 Jan 3;113 (1):125–46.
  46. Budoff MJ, Nasir K, Kinney GL, Hokanson JE, Barr RG, Steiner R et al. Сoronary artery and thoracic calcium on non-contrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD gene cohort. J Cardiovasc Comput Tomogr. 2011 Mar-Apr;5 (2):113–8.
  47. Lee WJ, Shin JH, Park SY. Relation of pulmonary function impairment and coronary artery calcification by multi-detector computed tomography in group exposed to inorganic dusts. Tuberc Respir Dis (Seoul). 2013 Feb;74 (2):56–62.
  48. Williams MC, Murchison JT, Edwards LD, Agustí A, Bakke P, Calverley PM et al. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 2014 Aug;69 (8):718–23.
  49. Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomography coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999 Mar;74 (3):243–52.
  50. Liang BM, Xu ZB, Yi Q, Ou XM, Feng YL. Association of chronic obstructive pulmonary disease with coronary artery disease. Chin Med J (Engl). 2013;126 (17):3205–8.
  51. Topsakal R, Kalay N, Ozdogru I, Cetinkaya Y, Oymak S, Kaya MG et al. Effects of chronic obstructive pulmonary disease on coronary atherosclerosis. Heart Vessels. 2009 May;24 (3):164–8.
  52. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983 Feb;51 (3):606.
  53. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J. 1990 Jun;119 (6):1262–7.
  54. Григорьева Н. Ю., Шарабрин Е. Г., Кузнецов А. Н., Королева Т. В., Блинов П. А., Шахов Е. Б. Состояние коронарного русла у больных ишемической болезнью сердца в сочетании с хронической обструктивной болезнью легких по данным селективной коронароангиографии. Кардиоваскулярная терапия и профилактика. 2012;11 (5):29–32.
  55. Topsakal R, Eryol NK, Abaci A, Oymak S, Ozdoğru I, Yilmaz Y et al. The relation between chronic obstructive pulmonary disease and coronary collateral vessels. Angiology. 2005 Nov-Dec;56 (6):651–6.
  56. Kumagai S, Takashima H, Waseda K, Ando H, Suzuki A, Uetani T et al. Prognostic impact of lipid contents on the target lesion in patients with drug eluting stent implantation. Heart Vessels. 2014 Nov;29 (6):761–8.
  57. Kumagai S, Ishii H, Takashima H, Waseda K, Kurita A, Ando H et al. Impact of chronic obstructive pulmonary disease on composition of left main coronary artery plaque with intermediate stenosis. Int J Cardiol. 2014 Jul;174 (3):865–6.
Zafiraki V. K., Skaletsky K. V., Kosmacheva E. D., Shulzhenko L. V., Ramazanov D. M., Omarov A. A. Coronary atherosclerosis in patients with chronic forms of ischemic heart disease in combination with chronic obstructive pulmonary disease (review). Russian Heart Journal. 2015;14 (6):369–375

To access this material please log in or register

Register Authorize
Ru En